Overview

Assessment of Safety and Efficacy of SGLT2is Among LN Patients

Status:
Not yet recruiting
Trial end date:
2025-01-30
Target enrollment:
Participant gender:
Summary
The aim of this study is to assess the safety and efficacy of SGLT2is among LN patients.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Ain Shams University
Treatments:
Dapagliflozin
Empagliflozin